Profil
Gerard Griffioen is currently the Chief Scientific Officer-Drug Discovery at reMYND NV.
He previously worked as a Principal at the University of Vienna and Katholieke Universiteit Leuven.
Dr. Griffioen obtained a doctorate degree from Vrije Universiteit Amsterdam in 1996.
Postes actifs de Gerard Griffioen
| Sociétés | Poste | Début |
|---|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Gerard Griffioen
| Sociétés | Poste | Fin |
|---|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Gerard Griffioen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Vienna
University of Vienna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vrije Universiteit Amsterdam
Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
















